NANOSPHERE INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2014-11-05: Form 8-K; Period of report 2014-11-05; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2014-10-27: Form 8-K; Period of report 2014-10-22; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2014-10-22: Form 8-K; Period of report 2014-10-22; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2014-10-21: Form 8-K; Period of report 2014-10-20; Description 1.02 Termination of a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 8.01 Other Events; Details 1.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2014-11-05 | 8-K | 2014-11-05 | 2.02 Results of Operations and Financial Condition | 2.02 On November 5, 2014, Nanosphere, Inc. (the “Company”) issued a press release announcing its financial results for its third quarter ended September 30, 2014. | d818028d8k.htm |
| 2014-10-27 | 8-K | 2014-10-22 | 1.01 Entry into a Material Definitive Agreement | 1.01 On October 27, 2014, Nanosphere, Inc. (the “Company”) completed an underwritten offering (the “Offering”) of 40,000,000 shares of its common stock, par value $0.01 per share (the “Shares”). | d810068d8k.htm |
| 2014-10-22 | 8-K | 2014-10-22 | 7.01 Regulation FD Disclosure | 7.01 On October 22, 2014, Nanosphere, Inc. (the “Company”) (Nasdaq: NSPH) announced that it has priced its previously announced underwritten public offering of 40,000,000 shares of its common stock at a public offering price of $0.50 per share. | d809471d8k.htm |
| 2014-10-21 | 8-K | 2014-10-20 | 1.02 Termination of a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 8.01 Other Events | 1.02 On March 18, 2014, Nanosphere, Inc. (the “Company”) entered into a common stock purchase agreement (the “Purchase Agreement”) with Aspire Capital Fund LLC (“Aspire Capital”), which provided that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital was committed to purchase up to an aggregate of $30 million of shares of the Company’s common stock over the 24-month term of the Purchase Agreement. 2.02 On October 21, 2014, the Company issued a press release announcing unaudited, preliminary partial financial results for its third quarter ended September 30, 2014. 7.01 On October 21, 2014, the Company announced that it has commenced an underwritten public offering of its common stock. 8.01 On October 21, 2014, the Company announced that the listing of its common stock will be transferred from the NASDAQ Global Market to the NASDAQ Capital Market effective October 23, 2014. | d807395d8k.htm |
| 2014-10-14 | 8-K | 2014-10-13 | 8.01 Other Events | 8.01 On October 13, 2014, Nanosphere, Inc. (the “Company’) announced that the Company received 510(k) clearance from the U.S. Food and Drug Administration (the “FDA”) for the Company’s Verigene® Enteric Pathogens Nucleic Acid Test (EP). | d804068d8k.htm |
| 2014-09-22 | 8-K | 2014-09-19 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 3.01 On September 19, 2014, Nanosphere, Inc. (the “Company’) received a deficiency letter from the Listing Qualifications Department of The NASDAQ Stock Market (the “Staff”), notifying the Company that, for the last 30 consecutive business days, the closing bid price of the Company’s common stock has not been maintained at the minimum required closing bid price of at least $1.00 per share as required for continued listing on The NASDAQ Global Market pursuant to Listing Rule 5450(a)(1) (“Minimum Bid Price Rule”). | d792706d8k.htm |
| 2014-09-04 | 8-K | 2014-09-04 | 8.01 Other Events | 8.01 On September 4, 2014, Nanosphere, Inc. (the “Company”) issued a press release announcing that it has engaged Jefferies LLC as the Company’s financial advisor to assist the Company in the development and evaluation of a full range of potential strategic alternatives for the Company. | d784437d8k.htm |
| 2014-08-20 | 8-K | 2014-08-18 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On August 18, 2014, the board of directors (the “Board”) of Nanosphere, Inc. (the “Company”), acting in accordance with Sections 3.3 and 3.4 of the Company’s Amended and Restated Bylaws, increased the size of the Board from seven to eight directors and elected Kristopher A. Wood to the Board to serve until the next annual meeting of stockholders of the Company and until his successor is elected and qualified or the earlier of his resignation, removal, disqualification or death. | d778275d8k.htm |
| 2014-08-06 | 8-K | 2014-08-06 | 2.02 Results of Operations and Financial Condition | 2.02 On August 6, 2014, Nanosphere, Inc. (the “Company”) issued a press release announcing its financial results for its second quarter ended June 30, 2014. | d771643d8k.htm |
| 2014-06-25 | 8-K | 2014-06-25 | 7.01 Regulation FD Disclosure | 7.01 On June 25, 2014, Nanosphere, Inc. (the “Company”) plans to host an investor conference call that will be accessible by live conference call and webcast at 8:30 a.m. | d747930d8k.htm |
| 2014-05-29 | 8-K | 2014-05-28 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 (a) Nanosphere, Inc. (the “Company”) held its annual meeting of shareholders on May 28, 2014 (the “Annual Meeting”). | d734857d8k.htm |
| 2014-05-07 | 8-K | 2014-05-07 | 2.02 Results of Operations and Financial Condition | 2.02 On May 7, 2014, Nanosphere, Inc. (the “Company”) issued a press release announcing its financial results for its first quarter ended March 31, 2014. | d722588d8k.htm |
| 2014-04-07 | 8-K | 2014-04-04 | 7.01 Regulation FD Disclosure | 7.01 On April 4, 2014, Nanosphere, Inc. (the “Company”) issue a press release to disclose and correct certain materially false and misleading reports and web site postings about transactions in the Company’s securities that the Company discovered on the afternoon of April 4, 2014. | d705923d8k.htm |
| 2014-03-20 | 8-K | 2014-03-20 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | d696471d8k.htm |
| 2014-03-18 | 8-K | 2014-03-18 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | d694396d8k.htm |
| 2014-02-12 | 8-K | 2014-02-12 | 2.02 Results of Operations and Financial Condition | 2.02 On February 12, 2014, Nanosphere, Inc. (the “Company”) issued a press release announcing its financial results for its fourth quarter and the full year ended December 31, 2013. | d677461d8k.htm |
| 2014-01-10 | 8-K | 2014-01-10 | 2.02 Results of Operations and Financial Condition | 2.02 On January 10, 2014, Nanosphere, Inc. (the “Company”) issued a press release announcing preliminary revenue and placement data for its fourth quarter and fiscal year ended December 31, 2013 and other recent developments. | d655179d8k.htm |